[HTML][HTML] The recombinant Bacille Calmette–Guérin vaccine VPM1002: ready for clinical efficacy testing

NE Nieuwenhuizen, PS Kulkarni, U Shaligram… - Frontiers in …, 2017 - frontiersin.org
The only licensed vaccine against tuberculosis (TB), bacille Calmette–Guérin (BCG),
protects against severe extrapulmonary forms of TB but is virtually ineffective against the …

Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines

H Peltola, PS Kulkarni, SV Kapre… - Clinical infectious …, 2007 - academic.oup.com
Mumps epidemics in Canada and the United States prompted us to review evidence for the
effectiveness of 5 different vaccine strains. Early trials with the Jeryl Lynn vaccine strain …

Expert review on global real-world vaccine effectiveness against SARS-CoV-2

S Chuenkitmongkol, R Solante, E Burhan… - Expert review of …, 2022 - Taylor & Francis
Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. While primary series vaccination rates are generally high in …

[HTML][HTML] Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia

FC Haidara, A Umesi, SO Sow, M Ochoge… - … England Journal of …, 2023 - Mass Medical Soc
Background An effective, affordable, multivalent meningococcal conjugate vaccine is
needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and …

[HTML][HTML] Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans

SO Sow, BJ Okoko, A Diallo, S Viviani… - … England Journal of …, 2011 - Mass Medical Soc
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …

[HTML][HTML] A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

PS Kulkarni, S Desai, T Tewari, A Kawade, N Goyal… - Vaccine, 2017 - Elsevier
Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing
countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human …

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial

MF Cotton, SA Madhi, AK Luabeya… - The Lancet Infectious …, 2022 - thelancet.com
Background Tuberculosis is a major public health problem worldwide. Immunisation with
Mycobacterium bovis BCG vaccine is partially effective in infants, reducing the incidence of …

Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic

R Solante, C Alvarez-Moreno, E Burhan… - Expert review of …, 2023 - Taylor & Francis
Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. However, the emergence of the Omicron variant and …

[HTML][HTML] A randomized, controlled trial of an aerosolized vaccine against measles

N Low, A Bavdekar, L Jeyaseelan… - … England Journal of …, 2015 - Mass Medical Soc
Background Aerosolized vaccine can be used as a needle-free method of immunization
against measles, a disease that remains a major cause of illness and death. Data on the …

[HTML][HTML] Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single …

WH Chen, KM Neuzil, CR Boyce, MF Pasetti… - The Lancet Infectious …, 2018 - thelancet.com
Background Invasive meningococcal disease is an important public health problem,
especially in sub-Saharan Africa. After introduction of MenAfriVac in 2010, Neisseria …